Dov Elefant
Overview
Dov Elefant received an average of $541K in total compensation, including $260K in salary, at Cellectar Biosciences from 2019 to 2021. Dov Elefant also received an average of $658K at Akari Therapeutics Plc between 2014 and 2015.
- 2021
- 2020
- 2019
- 2015
- 2014
Cellectar BiosciencesFormer Vice President and Chief Financial Officer
Cellectar BiosciencesVice President and Chief Financial Officer
Cellectar BiosciencesVice President and Chief Financial Officer
Akari Therapeutics PlcChief Financial Officer
Akari Therapeutics PlcChief Financial Officer
Source: SEC filings on April 29, 2022, May 13, 2021, April 28, 2020, and April 28, 2016.
Related executives
We found 19 more executives who work or worked at Cellectar Biosciences and Akari Therapeutics Plc.
James Caruso
Cellectar Biosciences
Chief Executive Officer
Rachelle Jacques
Akari Therapeutics Plc
Chief Executive Officer
Jarrod Longcor
Cellectar Biosciences
Chief Operating Officer
Chad Kolean
Cellectar Biosciences
Chief Financial Officer
Wendy DiCicco
Akari Therapeutics Plc
Chief Financial Officer
Torsten Hombeck
Akari Therapeutics Plc
Chief Financial Officer
John Friend
Cellectar Biosciences
Chief Medical Officer
Igor Grachev
Cellectar Biosciences